Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

Barclays logo

   Trade now with Barclays Stockbrokers   Trade now with Barclays   Sponsored by Barclays Stockbrokers

95.80p
   
  • Change Today:
      0.40p
  • 52 Week High: 102.00
  • 52 Week Low: 50.50
  • Currency: UK Pounds
  • Shares Issued: 514.21m
  • Volume: 279,599
  • Market Cap: £492.61m
  • RiskGrade: 154
  • Beta: 0.00

Alliance Pharma Overview

Alliance Pharma is in the pharma and biotech sector and is currently trading at 95.80p per share. In the last year Alliance Pharma's share price has ranged from 50.50p to 102.00p and brokers are currently rating this stock as 'strong buy'.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 1.4% 1.5%
Div Cover 4.0 3.0
Op Mrgn 29.2% 22.9%
ROCE 85.8%  
Latest F'cast
P/E 17.9 20.9
PEG 0.5 n/a
Pr/Revenue 4.7 4.0
Pr/Book 2.4  
Latest F'cast
Revenue 6.0% 19.5%
PBT 27.7% -0.4%
EPS 38.7% -14.5%
DPS 10.0% 12.7%

Alliance Pharma Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-13 45.28 12.01 3.82p 10.6 1.8 +6% 0.91p 2.2%
31-Dec-14 43.54 10.16 3.36p 10.9 n/a -12% 1.00p 2.7%
31-Dec-15 48.34 15.18 3.52p 12.2 2.4 +5% 1.10p 2.6%
31-Dec-16 97.49 22.22 3.85p 12.3 1.4 +9% 1.21p 2.6%
31-Dec-17 103.31 28.37 5.34p 12.6 0.3 +39% 1.33p 2.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Alliance Pharma Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-18 123.43 28.27 4.57p 20.9 n/a -14% 1.50p 1.5%
31-Dec-19 139.90 33.17 5.23p 18.2 1.2 +15% 1.60p 1.6%

Copyright © 2018 FactSet Research Systems Inc. All rights reserved.

Alliance Pharma Company Announcements

Marketing Authorisation for Diclectin 06-Jul-2018 07:00 RNS
Block Listing Six Monthly Return 29-Jun-2018 07:00 RNS
Notification of Major Holdings 25-Jun-2018 09:39 RNS

Alliance Pharma ShareCast News

Alliance Pharma's morning sickness treatment gai... 06-Jul-2018 ShareCast
Alliance Pharma completes £60m Nizoral acquisition 22-Jun-2018 ShareCast
Alliance Pharma buys Asia-Pacific rights to Nizo... 19-Jun-2018 ShareCast

Alliance Pharma Top Newspaper Links

Drug sales lead the way for Boots as revenues ri... 31-Oct-2008 The Scotsman
Look ahead 13-Sep-2006 Times
Look ahead 12-May-2006 Times

Latest Alliance Pharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 95.80p
Change Today 0.40p
% Change 0.42 %
52 Week High 102.00
52 Week Low 50.50
Volume 279,599
Shares Issued 514.21m
Market Cap £492.61m
Beta 0.00
RiskGrade 154

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
77.62% below the market average77.62% below the market average77.62% below the market average77.62% below the market average77.62% below the market average
42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average
Price Trend
94.16% above the market average94.16% above the market average94.16% above the market average94.16% above the market average94.16% above the market average
93.75% above the sector average93.75% above the sector average93.75% above the sector average93.75% above the sector average93.75% above the sector average
Income
61.14% below the market average61.14% below the market average61.14% below the market average61.14% below the market average61.14% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average
Growth
80.15% above the market average80.15% above the market average80.15% above the market average80.15% above the market average80.15% above the market average
85.71% above the sector average85.71% above the sector average85.71% above the sector average85.71% above the sector average85.71% above the sector average

What The Brokers Say

Strong Buy 1
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 14-Jun-18 21-Dec-17
Paid 11-Jul-18 11-Jan-18
Amount 0.89p 0.44p

Trades for 20-Jul-2018

Time Volume / Share Price
14:51 1 @ 95.80p
14:51 734 @ 95.80p
14:39 1,001 @ 95.23p
14:29 1,416 @ 96.00p
14:29 1,414 @ 96.00p

Alliance Pharma Key Personnel

CEO Peter Butterfield
CFO Andrew Franklin

Top of Page